Noninvasive total hemoglobin will be offered as part of the upgradable Masimo Rainbow SET technology platform. The Masimo Rainbow SET platform allows clinicians to noninvasively and continuously measure oxygen content, carboxyhemoglobin methemoglobin and total hemoglobin, in addition to oxyhemoglobin, perfusion index, and pulse rate. Masimo anticipates commercial availability for both SpHb and SpOC in the third quarter of 2008.
The availability of Masimo SpHb technology should make hemoglobin measurement more convenient and broadly available to clinicians in both hospital and outpatient settings – helping them make earlier and better clinical decisions, improve patient safety and decrease costs.
Michael O’Reilly, executive vice president of medical affairs at Masimo, said: “Masimo Rainbow SET SpHb has the potential to revolutionize the management of both acute and chronic anemia, as well as the therapeutic interventions used to treat these conditions. We believe SpHb will provide a significant advancement in patient safety for clinicians worldwide.”